Abbott Laboratories: Buying A Healthcare Giant On Sale

After reaching a cycle high of $141.23 per share in early March 2025, Abbott Laboratories closed at $92.48 as of April 23rd, the equivalent of a ~35% decline in just over a year. This is now one of the most severe drawdowns in the company's history, even exceeding in severity the price declines experienced during the 2008-09 global financial crisis. Along with the release of the Q1-26 earnings last week, management has guided for adjusted diluted EPS between $5.38 and $5.58 per share in fiscal 2026.